Giving Breath to Motor Neurons: Noninvasive Mechanical Ventilation Slows Disease Progression in Amyotrophic Lateral Sclerosis.


Journal

Annals of neurology
ISSN: 1531-8249
Titre abrégé: Ann Neurol
Pays: United States
ID NLM: 7707449

Informations de publication

Date de publication:
29 Jan 2024
Historique:
revised: 09 01 2024
received: 04 08 2023
accepted: 12 01 2024
medline: 29 1 2024
pubmed: 29 1 2024
entrez: 29 1 2024
Statut: aheadofprint

Résumé

Noninvasive mechanical ventilation (NIMV) improves amyotrophic lateral sclerosis (ALS) quality of life and survival. However, data about its effect on disease progression are still lacking. Here, we test whether NIMV use changed the rate of functional decline among ALS patients. In this retrospective observational study, we included 448 ALS patients followed up at the ALS Center in Turin, Italy, who underwent NIMV during the disease course. The primary outcome was the change in functional decline after NIMV initiation adjusting for covariates. Functional decline was based on the nonrespiratory items of the Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised (ALSFRS-R). NIMV initiation resulted in a slower functional decline (mean improvement = 0.16 points per month, 95% confidence interval = 0.12-0.19, p < 0.001), with consistent effects observed across various demographic factors, including sex, age at diagnosis, and disease duration before NIMV initiation. This finding was replicated using the PRO-ACT (Pooled Resource Open-Access ALS Clinical Trials) dataset. The favorable impact of NIMV on ALSFRS-R progression was evident independently of disease stages. Notably, NIMV benefits were not dose-dependent but were particularly prominent for nighttime respiratory support. NIMV significantly influences the rate of motor progression in ALS, and this effect is not determined by the nonlinearity of ALSFRS-R trajectory. The functional decline slowed following NIMV initiation, independently of the site of disease onset or disease severity at the time of NIMV initiation. Our findings underscore the importance of timely NIMV initiation for all ALS patients and highlight the need to consider NIMV-induced slowing of disease progression when evaluating clinical trial outcomes. ANN NEUROL 2024.

Identifiants

pubmed: 38284771
doi: 10.1002/ana.26875
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Ministero dell'Istruzione, dell'Università e della Ricerca
ID : 2017SNW5MB
Organisme : Seventh Framework Programme
ID : 259867
Organisme : Ministero della Salute
ID : RF-2016-02362405
Organisme : EU Joint Programme - Neurodegenerative Disease Research

Informations de copyright

© 2024 The Authors. Annals of Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association.

Références

Chiò A, Logroscino G, Traynor BJ, et al. Global epidemiology of amyotrophic lateral sclerosis: a systematic review of the published literature. Neuroepidemiology 2013;41:118-130. https://doi.org/10.1159/000351153.
Bourke SC, Tomlinson M, Williams TL, et al. Effects of non-invasive ventilation on survival and quality of life in patients with amyotrophic lateral sclerosis: a randomised controlled trial. Lancet Neurol 2006;5:140-147. https://doi.org/10.1016/S1474-4422(05)70326-4.
Rafiq MK, Proctor AR, McDermott CJ, Shaw PJ. Respiratory management of motor neurone disease: a review of current practice and new developments. Pract Neurol 2012;12:166-176. https://doi.org/10.1136/practneurol-2011-000199.
Radunovic A, Annane D, Rafiq MK, et al. Mechanical ventilation for amyotrophic lateral sclerosis/motor neuron disease. Cochrane Database Syst Rev 2017;10:CD004427. https://doi.org/10.1002/14651858.CD004427.pub4.
Chio A, Moglia C, Canosa A, et al. Respiratory support in a population-based ALS cohort: demographic, timing and survival determinants. J Neurol Neurosurg Psychiatry 2022;93:1024-1026. https://doi.org/10.1136/jnnp-2021-327968.
Atassi N, Cudkowicz ME, Schoenfeld DA. Advanced statistical methods to study the effects of gastric tube and non-invasive ventilation on functional decline and survival in amyotrophic lateral sclerosis. Amyotroph Lateral Scler 2011;12:272-277. https://doi.org/10.3109/17482968.2011.577786.
Chiò A, Mora G, Moglia C, et al. Secular trends of amyotrophic lateral sclerosis. JAMA Neurol 2017;74:1097-1104. https://doi.org/10.1001/jamaneurol.2017.1387.
Andersen PM, Borasio GD, Dengler R, et al. EFNS task force on management of amyotrophic lateral sclerosis: guidelines for diagnosing and clinical care of patients and relatives. Eur J Neurol 2005;12:921-938. https://doi.org/10.1111/j.1468-1331.2005.01351.x.
EFNS Task Force on Diagnosis and Management of Amyotrophic Lateral Sclerosis, Andersen PM, Abrahams S, et al. EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS)-revised report of an EFNS task force. Eur J Neurol 2012;19:360-375. https://doi.org/10.1111/j.1468-1331.2011.03501.x.
Strong MJ, Abrahams S, Goldstein LH, et al. Amyotrophic lateral sclerosis-frontotemporal spectrum disorder (ALS-FTSD): revised diagnostic criteria. Amyotroph Lateral Scler Frontotemporal Degener 2017;18:153-174. https://doi.org/10.1080/21678421.2016.1267768.
Balendra R, Jones A, Jivraj N, et al. Estimating clinical stage of amyotrophic lateral sclerosis from the ALS functional rating scale. Amyotroph Lateral Scler Frontotemporal Degener 2014;15:279-284. https://doi.org/10.3109/21678421.2014.897357.
Chiò A, Hammond ER, Mora G, et al. Development and evaluation of a clinical staging system for amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 2015;86:38-44. https://doi.org/10.1136/jnnp-2013-306589.
Atassi N, Berry J, Shui A, et al. The PRO-ACT database: design, initial analyses, and predictive features. Neurology 2014;83:1719-1725. https://doi.org/10.1212/WNL.0000000000000951.
Kiernan MC, Vucic S, Talbot K, et al. Improving clinical trial outcomes in amyotrophic lateral sclerosis. Nat Rev Neurol 2021;17:104-118. https://doi.org/10.1038/s41582-020-00434-z.
Dorst J, Ludolph AC. Non-invasive ventilation in amyotrophic lateral sclerosis. Ther Adv Neurol Disord 2019;12:175628641985704. https://doi.org/10.1177/1756286419857040.
Georges M, Morélot-Panzini C, Similowski T, Gonzalez-Bermejo J. Noninvasive ventilation reduces energy expenditure in amyotrophic lateral sclerosis. BMC Pulm Med 2014;14:17. https://doi.org/10.1186/1471-2466-14-17.
Hartmaier SL, Rhodes T, Cook SF, et al. Qualitative measures that assess functional disability and quality of life in ALS. Health Qual Life Outcomes 2022;20:12. https://doi.org/10.1186/s12955-022-01919-9.

Auteurs

Maurizio Grassano (M)

"Rita Levi Montalcini" Department of Neuroscience, University of Turin, Turin, Italy.

Emanuele Koumantakis (E)

Department of Public Health and Pediatrics, University of Turin, Turin, Italy.
Post Graduate School of Medical Statistics, University of Turin, Turin, Italy.

Umberto Manera (U)

"Rita Levi Montalcini" Department of Neuroscience, University of Turin, Turin, Italy.
Neurologia 1U, Azienda Ospedaliero Universitaria Città della Salute e della Scienza di Torino, Turin, Italy.

Antonio Canosa (A)

"Rita Levi Montalcini" Department of Neuroscience, University of Turin, Turin, Italy.
Neurologia 1U, Azienda Ospedaliero Universitaria Città della Salute e della Scienza di Torino, Turin, Italy.

Rosario Vasta (R)

"Rita Levi Montalcini" Department of Neuroscience, University of Turin, Turin, Italy.

Francesca Palumbo (F)

"Rita Levi Montalcini" Department of Neuroscience, University of Turin, Turin, Italy.

Giuseppe Fuda (G)

"Rita Levi Montalcini" Department of Neuroscience, University of Turin, Turin, Italy.

Paolina Salamone (P)

"Rita Levi Montalcini" Department of Neuroscience, University of Turin, Turin, Italy.

Giulia Marchese (G)

"Rita Levi Montalcini" Department of Neuroscience, University of Turin, Turin, Italy.

Federico Casale (F)

"Rita Levi Montalcini" Department of Neuroscience, University of Turin, Turin, Italy.

Lorena Charrier (L)

Department of Public Health and Pediatrics, University of Turin, Turin, Italy.

Gabriele Mora (G)

"Rita Levi Montalcini" Department of Neuroscience, University of Turin, Turin, Italy.

Cristina Moglia (C)

"Rita Levi Montalcini" Department of Neuroscience, University of Turin, Turin, Italy.
Neurologia 1U, Azienda Ospedaliero Universitaria Città della Salute e della Scienza di Torino, Turin, Italy.

Andrea Calvo (A)

"Rita Levi Montalcini" Department of Neuroscience, University of Turin, Turin, Italy.
Neurologia 1U, Azienda Ospedaliero Universitaria Città della Salute e della Scienza di Torino, Turin, Italy.

Adriano Chiò (A)

"Rita Levi Montalcini" Department of Neuroscience, University of Turin, Turin, Italy.
Neurologia 1U, Azienda Ospedaliero Universitaria Città della Salute e della Scienza di Torino, Turin, Italy.
Institute of Cognitive Sciences and Technologies, National Council of Research, Rome, Italy.

Classifications MeSH